161 related articles for article (PubMed ID: 36241925)
1. Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway.
Li S; Hu J; Li G; Mai H; Gao Y; Liang B; Wu H; Guo J; Duan Y
Cell Biol Toxicol; 2023 Aug; 39(4):1359-1375. PubMed ID: 36241925
[TBL] [Abstract][Full Text] [Related]
2. Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation.
Li N; Zhao Z; Miao F; Cai S; Liu P; Yu Y; Wang B
Cancer Gene Ther; 2021 May; 28(5):471-485. PubMed ID: 33199829
[TBL] [Abstract][Full Text] [Related]
3. Silence of lncRNA MIAT-mediated inhibition of DLG3 promoter methylation suppresses breast cancer progression via the Hippo signaling pathway.
Li D; Hu X; Yu S; Deng S; Yan M; Sun F; Song J; Tang L
Cell Signal; 2020 Sep; 73():109697. PubMed ID: 32593652
[TBL] [Abstract][Full Text] [Related]
4. Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway.
Wang HB; Wei H; Wang JS; Li L; Chen AY; Li ZG
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):708-723. PubMed ID: 30611858
[TBL] [Abstract][Full Text] [Related]
5. LINC00858 knockdown inhibits gastric cancer cell growth and induces apoptosis through reducing WNK2 promoter methylation.
Du J; Liang Y; Li J; Zhao JM; Lin XY
Cell Oncol (Dordr); 2020 Aug; 43(4):709-723. PubMed ID: 32447640
[TBL] [Abstract][Full Text] [Related]
6. Correction to: Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway.
Li S; Hu J; Li G; Mai H; Gao Y; Liang B; Wu H; Guo J; Duan Y
Cell Biol Toxicol; 2023 Dec; 39(6):3345. PubMed ID: 37578667
[No Abstract] [Full Text] [Related]
7. Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.
Wu DM; Zheng ZH; Zhang YB; Fan SH; Zhang ZF; Wang YJ; Zheng YL; Lu J
J Exp Clin Cancer Res; 2019 Jun; 38(1):237. PubMed ID: 31171015
[TBL] [Abstract][Full Text] [Related]
8. LINC00922 regulates epithelial-mesenchymal transition, invasive and migratory capacities in breast cancer through promoting NKD2 methylation.
Wang Y; Dong T; Wang P; Li S; Wu G; Zhou J; Wang Z
Cell Signal; 2021 Jan; 77():109808. PubMed ID: 33045317
[TBL] [Abstract][Full Text] [Related]
9. The phytochemical brazilin suppress DNMT1 expression by recruiting p53 to its promoter resulting in the epigenetic restoration of p21 in MCF7cells.
Chatterjee B; Ghosh K; Swain A; Nalla KK; Ravula H; Pan A; Kanade SR
Phytomedicine; 2022 Jan; 95():153885. PubMed ID: 34920321
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
[TBL] [Abstract][Full Text] [Related]
11. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.
Wu Y; Alvarez M; Slamon DJ; Koeffler P; Vadgama JV
BMC Cancer; 2010 Feb; 10():32. PubMed ID: 20132554
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA BZRAP1-AS1 silencing suppresses tumor angiogenesis in hepatocellular carcinoma by mediating THBS1 methylation.
Wang W; Chen G; Wang B; Yuan Z; Liu G; Niu B; Chen Y; Zhou S; He J; Xue H
J Transl Med; 2019 Dec; 17(1):421. PubMed ID: 31847842
[TBL] [Abstract][Full Text] [Related]
13. A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1.
Xu Q; Jiang Y; Yin Y; Li Q; He J; Jing Y; Qi YT; Xu Q; Li W; Lu B; Peiper SS; Jiang BH; Liu LZ
J Mol Cell Biol; 2013 Feb; 5(1):3-13. PubMed ID: 22935141
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LINC01270 is an onco-promotor in lung adenocarcinoma by upregulating LARP1 via sponging miR-326.
Zhang W; Cao C; Shen J; Shan S; Tong Y; Cai H; Han Z; Chai H
Bioengineered; 2022 Jun; 13(6):14472-14488. PubMed ID: 36694453
[TBL] [Abstract][Full Text] [Related]
15. Deleted in lymphocytic leukemia 2 induces retinoic acid receptor beta promoter methylation and mitogen activated kinase-like protein activation to enhance viability and mobility of colorectal cancer cells.
Fu L; Shi Z; Chen B
Bioengineered; 2022 May; 13(5):12847-12862. PubMed ID: 35611845
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
17. Abnormal promoter DNA hypermethylation of the integrin, nidogen, and dystroglycan genes in breast cancer.
Strelnikov VV; Kuznetsova EB; Tanas AS; Rudenko VV; Kalinkin AI; Poddubskaya EV; Kekeeva TV; Chesnokova GG; Trotsenko ID; Larin SS; Kutsev SI; Zaletaev DV; Nemtsova MV; Simonova OA
Sci Rep; 2021 Jan; 11(1):2264. PubMed ID: 33500458
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4.
Vernier M; McGuirk S; Dufour CR; Wan L; Audet-Walsh E; St-Pierre J; Giguère V
Oncogene; 2020 Oct; 39(41):6406-6420. PubMed ID: 32855526
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA ARAP1-AS1 accelerates cell proliferation and migration in breast cancer through miR-2110/HDAC2/PLIN1 axis.
Lu C; Wang X; Zhao X; Xin Y; Liu C
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32110804
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-induced hypomethylation and overexpression of YAP1 facilitate breast cancer cell growth and survival.
Muhammad JS; Guimei M; Jayakumar MN; Shafarin J; Janeeh AS; AbuJabal R; Eladl MA; Ranade AV; Ali A; Hamad M
Neoplasia; 2021 Jan; 23(1):68-79. PubMed ID: 33242831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
